{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:24:36Z","timestamp":1787671476091,"version":"build-2736575974"},"reference-count":102,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2120240615426"],"award-info":[{"award-number":["2120240615426"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-02217836"],"award-info":[{"award-number":["RS-2025-02217836"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00217595"],"award-info":[{"award-number":["RS-2023-00217595"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2022R1C1C1005741"],"award-info":[{"award-number":["2022R1C1C1005741"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.csbj.2025.12.035","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:52:43Z","timestamp":1767397963000},"page":"289-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systematic discovery of disease-modifying targets by prediction from knowledge graph-based AI model and experimental validation: Parkinson\u2019s disease case"],"prefix":"10.34133","volume":"31","author":[{"given":"Minyoung","family":"So","sequence":"first","affiliation":[{"name":"Standigm Inc., Seoul 06261, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Brain Science, Ajou University School of Medicine, Suwon 16499, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongin","family":"Kim","sequence":"additional","affiliation":[{"name":"Standigm Inc., Seoul 06261, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokjin","family":"Han","sequence":"additional","affiliation":[{"name":"Standigm Inc., Seoul 06261, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Koo","sequence":"additional","affiliation":[{"name":"Standigm Inc., Seoul 06261, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyong","family":"Kim","sequence":"additional","affiliation":[{"name":"Standigm Inc., Seoul 06261, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Gi","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Brain Science, Ajou University School of Medicine, Suwon 16499, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Brain Science, Ajou University School of Medicine, Suwon 16499, Republic of Korea"},{"name":"Department of Biomedical Science, Graduate School of Ajou University, Suwon 16499, South Korea"},{"name":"BK21 R&E Initiative for Advanced Precision Medicine, Ajou University School of Medicine, Suwon 16499, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0244-7"},{"key":"e_1_3_5_3_2","unstructured":"Statistics | Parkinson\u2019s Foundation n.d. \u3008https:\/\/www.parkinson.org\/understanding-parkinsons\/statistics\u3009 (accessed October 18 2024)."},{"key":"e_1_3_5_4_2","volume-title":"Parkinson disease: a public health approach: technical brief","author":"World Health Organization","year":"2022","unstructured":"World Health Organization : Parkinson disease: a public health approach: technical brief. : 2022."},{"key":"e_1_3_5_5_2","first-page":"427","article-title":"Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2023 update","volume":"13","author":"McFarthing K.","year":"2023","unstructured":"McFarthing K., Buff S., Rafaloff G., Fiske B., Mursaleen L., Fuest R. et al: Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2023 update. J Park\u2019S Dis 2023; 13: 427.","journal-title":"J Park\u2019S Dis"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0024-5"},{"key":"e_1_3_5_7_2","first-page":"1","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You Y.","year":"2022","unstructured":"You Y., Lai X., Pan Y., Zheng H., Vera J., Liu S. et al: Artificial intelligence in cancer target identification and drug discovery. Sig Transduct Target Ther 2022; 7: 1.","journal-title":"Sig Transduct Target Ther"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/01655515221112844","article-title":"Knowledge-graph-based explainable AI: a systematic review","volume":"50","author":"Rajabi E.","year":"2024","unstructured":"Rajabi E. and Etminani K.: Knowledge-graph-based explainable AI: a systematic review. J Inf Sci 2024; 50: 1019.","journal-title":"J Inf Sci"},{"key":"e_1_3_5_9_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-0716-3449-3_9","article-title":"Knowledge graphs and their applications in drug discovery","volume":"2716","author":"James T.","year":"2024","unstructured":"James T. and Hennig H.: Knowledge graphs and their applications in drug discovery. Methods Mol Biol 2024; 2716: 203.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_5_10_2","article-title":"Standigm ASK\u2122: knowledge graph and artificial intelligence platform applied to target discovery in idiopathic pulmonary fibrosis","volume":"25","author":"Han S.","year":"2024","unstructured":"Han S., Lee J.E., Kang S., So M., Jin H., Lee J.H. et al: Standigm ASK\u2122: knowledge graph and artificial intelligence platform applied to target discovery in idiopathic pulmonary fibrosis. Brief Bioinforma 2024; 25.","journal-title":"Brief Bioinforma"},{"key":"e_1_3_5_11_2","doi-asserted-by":"crossref","unstructured":"Research C for DE and. FDA Adverse Event Reporting System (FAERS) Database. FDA 2024.","DOI":"10.2139\/ssrn.4583117"},{"key":"e_1_3_5_12_2","article-title":"STARGEO: expression signatures for disease using crowdsourced GEO annotation","author":"Himmelstein D.","year":"2015","unstructured":"Himmelstein D., Bastian F., Hadley D. and Greene C.: STARGEO: expression signatures for disease using crowdsourced GEO annotation. Thinklab 2015; .","journal-title":"Thinklab"},{"key":"e_1_3_5_13_2","article-title":"The clinical genome resource (ClinGen): advancing genomic knowledge through global curation","volume":"0","author":"Andersen E.F.","year":"2024","unstructured":"Andersen E.F., Azzariti D.R., Babb L., Berg J.S., Biesecker L.G., Bly Z. et al: The clinical genome resource (ClinGen): advancing genomic knowledge through global curation. Genet Med 2024; 0.","journal-title":"Genet Med"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1120"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1046"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq099"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"D1333","DOI":"10.1093\/nar\/gkad1005","article-title":"The human phenotype ontology in 2024: phenotypes around the world","volume":"52","author":"Gargano M.A.","year":"2024","unstructured":"Gargano M.A., Matentzoglu N., Coleman B., Addo-Lartey E.B., Anagnostopoulos A.V., Anderton J. et al: The human phenotype ontology in 2024: phenotypes around the world. Nucleic Acids Res 2024; 52: D1333.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_18_2","author":"Vasilevsky N.","year":"2022","unstructured":"Vasilevsky N., Matentzoglu N., Toro S., Flack J., Hegde H., Unni D. et al: Mondo Unifying Dis World worl 2022; .","journal-title":"Mondo Unifying Dis World worl"},{"key":"e_1_3_5_19_2","first-page":"2735","volume-title":"Quaternion knowledge graph embeddingsProceedings of the 33rd International Conference on Neural Information Processing Systems","author":"Zhang S.","year":"2019","unstructured":"Zhang S., Tay Y., Yao L. and Liu Q.: Quaternion knowledge graph embeddings. Proceedings of the 33rd International Conference on Neural Information Processing Systems. Red Hook, NY, USA: Curran Associates Inc 2019: 2735."},{"key":"e_1_3_5_20_2","article-title":"Modeling relational data with graph convolutional","author":"Schlichtkrull M.","year":"2017","unstructured":"Schlichtkrull M., Kipf T.N., Bloem P., Berg R., van den, Titov I. and Welling M.: Modeling relational data with graph convolutional. Networks 2017; .","journal-title":"Networks"},{"key":"e_1_3_5_21_2","author":"Veli\u010dkovi\u0107 P.","year":"2018","unstructured":"Veli\u010dkovi\u0107 P., Cucurull G., Casanova A., Romero A., Li\u00f2 P. and Bengio Y.: Graph Atten Netw 2018; .","journal-title":"Graph Atten Netw"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","unstructured":"Hu B. Shi C. Zhao W.X. Yu P.S. Leveraging Meta-path based Context for Top- N Recommendation with A Neural Co-Attention Model. Proceedings of the 24th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining New York NY USA: Association for Computing Machinery; 2018 p. 1531\u20131540. https:\/\/doi.org\/10.1145\/3219819.3219965.","DOI":"10.1145\/3219819.3219965"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac757"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01061-1"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0969-x"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193"},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.763777","article-title":"Disease duration influences gene expression in neuromelanin-positive cells from Parkinson\u2019s disease patients","volume":"14","author":"Tiklov\u00e1 K.","year":"2021","unstructured":"Tiklov\u00e1 K., Gillberg L., Volakakis N., Lund\u00e9n-Miguel H., Dahl L., Serrano G.E. et al: Disease duration influences gene expression in neuromelanin-positive cells from Parkinson\u2019s disease patients. Front Mol Neurosci 2021; 14: 763777.","journal-title":"Front Mol Neurosci"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.08.025"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5607\/en23007","article-title":"Monitoring \u03b1-synuclein Aggregation Induced by Preformed \u03b1-synuclein Fibrils in an In Vitro Model System","volume":"32","author":"Kim B.J.","year":"2023","unstructured":"Kim B.J., Noh H.R., Jeon H. and Park S.M.: Monitoring \u03b1-synuclein Aggregation Induced by Preformed \u03b1-synuclein Fibrils in an In Vitro Model System. Exp Neurobiol 2023; 32: 147.","journal-title":"Exp Neurobiol"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.133289"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12864-021-07502-8","article-title":"Pathway size matters: the influence of pathway granularity on over-representation (enrichment analysis) statistics","volume":"22","author":"Karp P.D.","year":"2021","unstructured":"Karp P.D., Midford P.E., Caspi R. and Khodursky A.: Pathway size matters: the influence of pathway granularity on over-representation (enrichment analysis) statistics. BMC Genom 2021; 22: 191.","journal-title":"BMC Genom"},{"key":"e_1_3_5_33_2","volume-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects","author":"Kouli A.","year":"2018","unstructured":"Kouli A., Torsney K.M. and Kuan W.-L.: Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Edited by T.B. Stoker and J.C. Greenland. Brisbane (AU): Codon Publications 2018."},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba1659","article-title":"Promising disease-modifying therapies for Parkinson\u2019s disease","volume":"11","author":"Dawson V.L.","year":"2019","unstructured":"Dawson V.L. and Dawson T.M.: Promising disease-modifying therapies for Parkinson\u2019s disease. Sci Transl Med 2019; 11.","journal-title":"Sci Transl Med"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.136"},{"key":"e_1_3_5_36_2","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.014294","article-title":"Targeting mitophagy in Parkinson\u2019s disease","volume":"296","author":"Clark E.H.","year":"2021","unstructured":"Clark E.H., Torre A.V. de la, Hoshikawa T. and Briston T.: Targeting mitophagy in Parkinson\u2019s disease. J Biol Chem 2021; 296.","journal-title":"J Biol Chem"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091377"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-981-10-6583-5_12","article-title":"Therapeutic activities of DJ-1 and its binding compounds against neurodegenerative diseases","volume":"1037","author":"Inden M.","year":"2017","unstructured":"Inden M., Yanagisawa D., Hijioka M., Ariga H. and Kitamura Y.: Therapeutic activities of DJ-1 and its binding compounds against neurodegenerative diseases. Adv Exp Med Biol 2017; 1037: 187.","journal-title":"Adv Exp Med Biol"},{"key":"e_1_3_5_39_2","volume-title":"GeneReviews\u00ae","author":"Cook Shukla L.","year":"1993","unstructured":"Cook Shukla L., Schulze J., Farlow J., Pankratz N.D., Wojcieszek J. and Foroud T.: Parkinson disease overview. In: GeneReviews\u00ae. Edited by M.P. Adam, J. Feldman, G.M. Mirzaa, R.A. Pagon, S.E. Wallace and A. Amemiya. Seattle (WA): University of Washington, Seattle 1993."},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70266-2"},{"key":"e_1_3_5_41_2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/s41418-019-0482-7","article-title":"Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1","volume":"27","author":"Liu W.","year":"2020","unstructured":"Liu W., Duan X., Xu L., Shang W., Zhao J., Wang L. et al: Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1. Cell Death Differ 2020; 27: 2014.","journal-title":"Cell Death Differ"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104553"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/s41598-017-07181-0","article-title":"Mitochondrial division inhibitor-1 is neuroprotective in the A53T-\u03b1-synuclein rat model of Parkinson\u2019s disease","volume":"7","author":"Bido S.","year":"2017","unstructured":"Bido S., Soria F.N., Fan R.Z., Bezard E. and Tieu K.: Mitochondrial division inhibitor-1 is neuroprotective in the A53T-\u03b1-synuclein rat model of Parkinson\u2019s disease. Sci Rep 2017; 7: 7495.","journal-title":"Sci Rep"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6244"},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","DOI":"10.1038\/srep32656","article-title":"Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson\u2019s disease model induced by MPTP","volume":"6","author":"Filichia E.","year":"2016","unstructured":"Filichia E., Hoffer B., Qi X. and Luo Y.: Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson\u2019s disease model induced by MPTP. Sci Rep 2016; 6: 32656.","journal-title":"Sci Rep"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.05.019"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb1540"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2018.11.001"},{"key":"e_1_3_5_49_2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.26243","article-title":"The role of ATP13A2 in Parkinson\u2019s disease: clinical phenotypes and molecular mechanisms","volume":"30","author":"Park J.-S.","year":"2015","unstructured":"Park J.-S., Blair N.F. and Sue C.M.: The role of ATP13A2 in Parkinson\u2019s disease: clinical phenotypes and molecular mechanisms. Mov Disord 2015; 30: 770.","journal-title":"Mov Disord"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"119.e7","DOI":"10.1016\/j.neurobiolaging.2020.10.019","article-title":"Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson\u2019s disease","volume":"100","author":"Saini P.","year":"2021","unstructured":"Saini P., Rudakou U., Yu E., Ruskey J.A., Asayesh F., Laurent S.B. et al: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson\u2019s disease. Neurobiol Aging 2021; 100: 119.e7.","journal-title":"Neurobiol Aging"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2101-1"},{"key":"e_1_3_5_52_2","first-page":"33","article-title":"Pathological pathways and alpha-synuclein in Parkinson\u2019s disease: a view from the periphery","volume":"28","author":"Basellini M.J.","year":"2023","unstructured":"Basellini M.J., Kothuis J.M., Comincini A., Pezzoli G., Cappelletti G. and Mazzetti S.: Pathological pathways and alpha-synuclein in Parkinson\u2019s disease: a view from the periphery. FBL 2023; 28: 33.","journal-title":"FBL"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2019.08.002"},{"key":"e_1_3_5_54_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060954","article-title":"Roles of PTEN with DNA repair in Parkinson\u2019s disease","volume":"17","author":"Ogino M.","year":"2016","unstructured":"Ogino M., Ichimura M., Nakano N., Minami A., Kitagishi Y. and Matsuda S.: Roles of PTEN with DNA repair in Parkinson\u2019s disease. Int J Mol Sci 2016; 17: E954.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.07.013"},{"key":"e_1_3_5_56_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fneur.2019.00555","article-title":"The interaction of genetic mutations in PARK2 and FA2H causes a novel phenotype in a case of childhood-onset movement disorder","volume":"10","author":"Benger M.","year":"2019","unstructured":"Benger M., Mankad K., Proukakis C., Mazarakis N.D. and Kinali M.: The interaction of genetic mutations in PARK2 and FA2H causes a novel phenotype in a case of childhood-onset movement disorder. Front Neurol 2019; 10: 555.","journal-title":"Front Neurol"},{"key":"e_1_3_5_57_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s100480100111","article-title":"Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism","volume":"3","author":"Leung J.C.","year":"2001","unstructured":"Leung J.C., Klein C., Friedman J., Vieregge P., Jacobs H., Doheny D. et al: Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 2001; 3: 133.","journal-title":"Neurogenetics"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113022"},{"key":"e_1_3_5_59_2","article-title":"Serum butyrylcholinesterase activity: a biomarker for Parkinson\u2019s disease and related dementia","volume":"2017","author":"Dong M.-X.","year":"2017","unstructured":"Dong M.-X., Xu X.-M., Hu L., Liu Y., Huang Y.-J. and Wei Y.-D.: Serum butyrylcholinesterase activity: a biomarker for Parkinson\u2019s disease and related dementia. BioMed Res Int 2017; 2017: 1524107.","journal-title":"BioMed Res Int"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-161020"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105411"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28405"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/42166"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01478-2"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01061-1"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2025.04.005"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/3311"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad350"},{"key":"e_1_3_5_69_2","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1074\/jbc.M806947200","article-title":"Structure of Tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis *","volume":"284","author":"Pal A.","year":"2009","unstructured":"Pal A., Kraetzner R., Gruene T., Grapp M., Schreiber K., Gr\u00f8nborg M. et al: Structure of Tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis *. J Biol Chem 2009; 284: 3976.","journal-title":"J Biol Chem"},{"key":"e_1_3_5_70_2","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1074\/jbc.M806943200","article-title":"Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis *","volume":"284","author":"Guhaniyogi J.","year":"2009","unstructured":"Guhaniyogi J., Sohar I., Das K., Stock A.M. and Lobel P.: Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis *. J Biol Chem 2009; 284: 3985.","journal-title":"J Biol Chem"},{"key":"e_1_3_5_71_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111058","article-title":"Treadmill exercise reduces \u03b1-synuclein spreading via PPAR\u03b1","volume":"40","author":"Dutta D.","year":"2022","unstructured":"Dutta D., Paidi R.K., Raha S., Roy A., Chandra S. and Pahan K.: Treadmill exercise reduces \u03b1-synuclein spreading via PPAR\u03b1. Cell Rep 2022; 40.","journal-title":"Cell Rep"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(98)00333-9"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0138-8"},{"key":"e_1_3_5_74_2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1073\/pnas.1719808115","article-title":"Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar A\u03b2 by multiple endoproteolytic cleavages within the \u03b2-sheet domain","volume":"115","author":"Sol\u00e9-Dom\u00e8nech S.","year":"2018","unstructured":"Sol\u00e9-Dom\u00e8nech S., Rojas A.V., Maisuradze G.G., Scheraga H.A., Lobel P. and Maxfield F.R.: Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar A\u03b2 by multiple endoproteolytic cleavages within the \u03b2-sheet domain. PNAS 2018; 115: 1493.","journal-title":"PNAS"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123105"},{"key":"e_1_3_5_76_2","article-title":"Progress in disease-modifying therapies for Parkinson\u2019s disease","volume":"0","author":"Zhang S.","year":"2025","unstructured":"Zhang S., Shao G., Wu B., Xia L., Wang L., Li L. et al: Progress in disease-modifying therapies for Parkinson\u2019s disease. Aging Dis 2025; 0.","journal-title":"Aging Dis"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00061-2"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2019.10.002"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00620-8"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23860"},{"key":"e_1_3_5_81_2","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ymgme.2017.12.255","article-title":"Molecular basis of CLN2 disease: a review and classification of TPP1 gene variants reported worldwide","volume":"123","author":"Mole S.E.","year":"2018","unstructured":"Mole S.E., Gardner E., Schulz A. and Xin W.W.: Molecular basis of CLN2 disease: a review and classification of TPP1 gene variants reported worldwide. Mol Genet Metab 2018; 123: S97.","journal-title":"Mol Genet Metab"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.03.025"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412047200"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313173200"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008562200"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.2196\/46777"},{"key":"e_1_3_5_87_2","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1109\/JBHI.2020.2990797","article-title":"Knowledge graph-enabled cancer data analytics","volume":"24","author":"Hasan S.M.S.","year":"2020","unstructured":"Hasan S.M.S., Rivera D., Wu X.-C., Durbin E.B., Christian J.B. and Tourassi G.: Knowledge graph-enabled cancer data analytics. IEEE J Biomed Health Inform 2020; 24: 1952.","journal-title":"IEEE J Biomed Health Inform"},{"key":"e_1_3_5_88_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/24699322.2020.1850866","article-title":"Construction of a knowledge graph for diabetes complications from expert-reviewed clinical evidences","volume":"25","author":"Wang L.","year":"2020","unstructured":"Wang L., Xie H., Han W., Yang X., Shi L., Dong J. et al: Construction of a knowledge graph for diabetes complications from expert-reviewed clinical evidences. Comput Assist Surg 2020; 25: 29.","journal-title":"Comput Assist Surg"},{"key":"e_1_3_5_89_2","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac279","article-title":"Implications of topological imbalance for representation learning on biomedical knowledge graphs","volume":"23","author":"Bonner S.","year":"2022","unstructured":"Bonner S., Kirik U., Engkvist O., Tang J. and Barrett I.P.: Implications of topological imbalance for representation learning on biomedical knowledge graphs. Brief Bioinform 2022; 23: bbac279.","journal-title":"Brief Bioinform"},{"key":"e_1_3_5_90_2","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giae001","article-title":"The probability of edge existence due to node degree: a baseline for network-based predictions","volume":"13","author":"Zietz M.","year":"2024","unstructured":"Zietz M., Himmelstein D.S., Kloster K., Williams C., Nagle M.W. and Greene C.S.: The probability of edge existence due to node degree: a baseline for network-based predictions. Gigascience 2024; 13: giae001.","journal-title":"Gigascience"},{"key":"e_1_3_5_91_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13326-024-00308-z","article-title":"Elucidating the semantics-topology trade-off for knowledge inference-based pharmacological discovery","volume":"15","author":"Sosa D.N.","year":"2024","unstructured":"Sosa D.N., Neculae G., Fauqueur J. and Altman R.B.: Elucidating the semantics-topology trade-off for knowledge inference-based pharmacological discovery. J Biomed Semant 2024; 15: 5.","journal-title":"J Biomed Semant"},{"key":"e_1_3_5_92_2","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac481","article-title":"Ensembles of knowledge graph embedding models improve predictions for drug discovery","volume":"23","author":"Rivas-Barragan D.","year":"2022","unstructured":"Rivas-Barragan D., Domingo-Fern\u00e1ndez D., Gadiya Y. and Healey D.: Ensembles of knowledge graph embedding models improve predictions for drug discovery. Brief Bioinform 2022; 23: bbac481.","journal-title":"Brief Bioinform"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.8b00626"},{"key":"e_1_3_5_94_2","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae043","article-title":"KGE-UNIT: toward the unification of molecular interactions prediction based on knowledge graph and multi-task learning on drug discovery","volume":"25","author":"Zhang C.","year":"2024","unstructured":"Zhang C., Zang T. and Zhao T.: KGE-UNIT: toward the unification of molecular interactions prediction based on knowledge graph and multi-task learning on drug discovery. Brief Bioinform 2024; 25: bbae043.","journal-title":"Brief Bioinform"},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32111-8"},{"key":"e_1_3_5_96_2","article-title":"Neural Re-ranking in multi-stage","author":"Liu W.","year":"2022","unstructured":"Liu W., Xi Y., Qin J., Sun F., Chen B., Zhang W. et al: Neural Re-ranking in multi-stage. Recomm Syst A Rev 2022; .","journal-title":"Recomm Syst A Rev"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-024-02341-3"},{"key":"e_1_3_5_98_2","article-title":"Graph retrieval-augmented","author":"Peng B.","year":"2024","unstructured":"Peng B., Zhu Y., Liu Y., Bo X., Shi H., Hong C. et al: Graph retrieval-augmented. Gener A Surv 2024; .","journal-title":"Gener A Surv"},{"key":"e_1_3_5_99_2","article-title":"Retrieval-augmented generation with graphs","author":"Han H.","year":"2025","unstructured":"Han H., Wang Y., Shomer H., Guo K., Ding J., Lei Y. et al: Retrieval-augmented generation with graphs. GraphRAG) 2025; .","journal-title":"GraphRAG)"},{"key":"e_1_3_5_100_2","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae560","article-title":"Biomedical knowledge graph-optimized prompt generation for large language models","volume":"40","author":"Soman K.","year":"2024","unstructured":"Soman K., Rose P.W., Morris J.H., Akbas R.E., Smith B., Peetoom B. et al: Biomedical knowledge graph-optimized prompt generation for large language models. Bioinformatics 2024; 40: btae560.","journal-title":"Bioinformatics"},{"key":"e_1_3_5_101_2","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae353","article-title":"KRAGEN: a knowledge graph-enhanced RAG framework for biomedical problem solving using large language models","volume":"40","author":"Matsumoto N.","year":"2024","unstructured":"Matsumoto N., Moran J., Choi H., Hernandez M.E., Venkatesan M., Wang P. et al: KRAGEN: a knowledge graph-enhanced RAG framework for biomedical problem solving using large language models. Bioinformatics 2024; 40: btae353.","journal-title":"Bioinformatics"},{"key":"e_1_3_5_102_2","author":"Min C.","year":"2025","unstructured":"Min C., Mathew R., Pan J., Bansal S., Keshavarzi A. and Kannan A.V.: Effic Knowl Graph Constr Retr Unstructured Text LargeScale RAG Syst 2025; .","journal-title":"Effic Knowl Graph Constr Retr Unstructured Text LargeScale RAG Syst"},{"key":"e_1_3_5_103_2","author":"Xiang Z.","year":"2025","unstructured":"Xiang Z., Wu C., Zhang Q., Chen S., Hong Z., Huang X. et al: When Use Graphs RAG A Compr Anal Graph RetrAugment Gener 2025; .","journal-title":"When Use Graphs RAG A Compr Anal Graph RetrAugment Gener"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025005707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025005707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.12.035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:24:51Z","timestamp":1778012691000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.12.035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":102,"alternative-id":["10.1016\/j.csbj.2025.12.035"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.12.035","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic discovery of disease-modifying targets by prediction from knowledge graph-based AI model and experimental validation: Parkinson\u2019s disease case","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}